Product Information
VERAPAMIL SR 360 MG CAPSULE is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $7.8839 per EA under NDC 52536088601. Its NADAC has been published 76 times since Mar 12, 2025.
FDA first approved this application on May 29, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
360 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536088601
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019614FDA Approved
5/29/1990
TE Code
AB
On Market Since
5/29/1990
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL SR 360 MG CAPSULE has been published 76 times since Mar 12, 2025, and over the history we have for it it has risen 91.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.8839 per EA |
|---|---|
| All-time high | $8.4534 (May 13, 2026) |
| All-time low | $4.1131 (Mar 12, 2025) |
| 52-week high | $8.4534 |
| 52-week low | $4.4026 |
| Median price | $7.6532 |
| Average price | $6.5782 |
| Largest weekly change | +28.4% (Oct 22, 2025) |
| Weeks tracked | 76 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VERAPAMIL SR 360 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL SR 360 MG CAPSULE, manufactured by Wilshire Pharmaceuticals Inc., is $7.8839 per EA (NDC 52536088601), effective Aug 19, 2026.
How has the price of VERAPAMIL SR 360 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL SR 360 MG CAPSULE has risen 91.7%. It has been tracked across 76 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for VERAPAMIL SR 360 MG CAPSULE?
Since Mar 12, 2025, the NADAC for VERAPAMIL SR 360 MG CAPSULE has ranged from a low of $4.1131 (Mar 12, 2025) to a high of $8.4534 (May 13, 2026), with a median of $7.6532 per EA.
Are there cheaper alternatives to VERAPAMIL SR 360 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VERAPAMIL SR 360 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures VERAPAMIL SR 360 MG CAPSULE?
VERAPAMIL SR 360 MG CAPSULE (NDC 52536088601) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.